secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evommune, Inc. (EVMN)
CIK:        0002044725
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001193125-25-272282
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evommune amends charter and bylaws upon IPO closing on Nov 7, 2025
------------------------------------------------------------------

- Filed amended and restated certificate of incorporation with Delaware Secretary of State on November 7, 2025.
- Adopted amended and restated bylaws effective immediately prior to IPO closing, as pre-approved by board and stockholders.
- IPO closed on November 7, 2025; amendments are standard governance updates for a public company.
- Company is an emerging growth company trading on NYSE under symbol EVMN.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2044725/000119312525272282/0001193125-25-272282-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2044725/000119312525272282/d38367d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-272282

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer